PMC4727695_01
F-18 fluorodeoxyglucose (FDG) positron emission tomography-computed tomographic study demonstrates an ill-defined hypermetabolic soft tissue lesion located deep to the right breast and along the right anterior chest wall, concerning for neoplastic process. There is a large non-FDG avid fluid density collection in the right breast and overlying the hypermetabolic lesion, likely representing a seroma. Left breast implant is noted. No other suspicious FDG avid lesion or lymph node to suggest systemic involvement of malignancy was identified.
gox-3-e586-g001.jpg
PMC4727695_01_gox-3-e586-g001.jpg
F1
F-18 fluorodeoxyglucose uptake localized to the right anterior chest wall (Fig. 1). Further extensive workup ruled out another primary site of SCC.
Intraoperative view of right breast (which has previously been explanted) demonstrating dramatic enlargement with obvious thinning and attenuation of the soft tissue envelope.
gox-3-e586-g002.jpg
PMC4727695_01_gox-3-e586-g002.jpg
F2
Intraoperatively, a large recurrent right breast seroma was evident (Fig. 2).
Intraoperative appearance of in situ posterior capsule.
gox-3-e586-g003.jpg
PMC4727695_01_gox-3-e586-g003.jpg
F3
A fungating mass involving the posterior aspect of the subglandular capsule was noted (Fig. 3).
Mastectomy specimen with visible fungating mass on posterior capsule. Isosulfan blue dye present from aborted sentinel lymph node biopsy.
gox-3-e586-g004.jpg
PMC4727695_01_gox-3-e586-g004.jpg
F4
To perform en bloc resection, portions of the pectoralis major and minor were removed along with the subglandular capsule (Fig. 4).